🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

37.5 Gram(s) Serving Size
25 Servings
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
160 Calorie(s)
Total Fat
5 Gram(s) (8% DV)
Cholesterol
180 mg (60% DV)
Total Carbohydrates
5 Gram(s) (2% DV)
Protein
25 Gram(s) (50% DV)
Calcium
180 mg (18% DV)
Sodium
100 mg (4% DV)
Potassium
240 mg (6% DV)

Other Ingredients

hydrolyzed Whey Protein Phospholipid Hybrid Cocoa powder Natural & Artificial flavors Gum Blend Soy Lecitin Enzymes Acesulfame Potassium Sucralose

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions For Use: MyGenin is super delicious and easy to use. Mix 1 scoop of MyoGenin in 6 to 8 ounces of cold water or milk and drink immediately. MyoGenin mixes easily with a spoon and even better in a shaker bottle. When To Use: The most important time to use MyoGenin is within 1 hour after your workout. This is when mTOR activation is most critical. The other important times to take MyoGenin are before bed and immediately after you wake up. This keeps you activating mTOR and maximizing muscle-building protein synthesis.

⚠️ Warnings & Precautions

Allergen Information: Contains milk and soy.

Notice: Use this product as a food supplement. Do not use for weight reduction.

Keep out of reach of children.

🧪 Formulation Notes

25g Protein per serving

Allergen Information: Contains milk and soy.

Additional Information

mTOR activation technology Fast acting New! Integrated mTOR activation technology Hydrolyzed whey protein phospholipid hybrid 2 Phase leucine release Hydrolyzed peptide fractions Leucine specific hydrolysis More lean muscle growth

MyoGenin is unlike any other protein in the world and represents a major breakthrough in muscle-building protein synthesis. Breakthrough protein technology Until now, you've had whey protein, casein protein, egg protein, soy protein and various blends of these. MyoGenin is a completely new category of muscle-building protein. This advance and very unique protein hybrid incorporates a special 2-stage hydrolyzed whey protein that is integrated with target-specific active enzymes engineered to release leucine peptides in the body. These active enzymes are embedded and protected within the protein structure through a special phospholipid membrane and are engineered to actively target the cleavage sites at the leucine attachments on the peptide chain. This target-specific activation releases a flood of leucine within the body from the bioactive peptides after it's consumed. mTOR activator Leucine is the primary activator of mTOR - the main cellular signaling complex for up-regulating muscle protein synthesis.

When mTOR is activated , muscle protein synthesis increases dramatically. The greater the activation of mTOR, the more muscle protein your body will synthesis and the more muscle you will build. MyoGenin - The future of muscle

Made in USA

REV# MYO1116

EEC approved plant # 3003107574

Contents packaged by weight - not volume. Some settling may occur.

Storage Directions: Store in a cool dry place.

New!

Product Details

UPC / SKU 7 05077 00318 2
DSLD Entry Date 2017-05-24
Product Type Other Combinations
Form Powder
DSLD ID 74142
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →